Bob Hopkins
Stock Analyst at B of A Securities
(1.51)
# 1,492
Out of 4,653 analysts
59
Total ratings
65.71%
Success rate
-19.74%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $87.59 | +14.17% | 5 | Oct 22, 2024 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $225 → $185 | $172.93 | +6.98% | 4 | Jun 3, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $3.86 | +16.58% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $85.91 | -44.13% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $115.03 | +15.62% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $6.45 | +1,016.28% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $537.80 | -52.90% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $233.51 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $28.59 | +232.28% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $151.87 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $101.20 | -70.36% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 → $74 | $4.07 | +1,718.18% | 5 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $86.00 | +22.09% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $31.70 | +161.83% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $227.17 | +14.45% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $81.10 | - | 1 | Nov 10, 2017 |
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $87.59
Upside: +14.17%
Inspire Medical Systems
Jun 3, 2024
Maintains: Neutral
Price Target: $225 → $185
Current: $172.93
Upside: +6.98%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $3.86
Upside: +16.58%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $85.91
Upside: -44.13%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $115.03
Upside: +15.62%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $6.45
Upside: +1,016.28%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $537.80
Upside: -52.90%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $233.51
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $28.59
Upside: +232.28%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $151.87
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $101.20
Upside: -70.36%
Aug 9, 2019
Reiterates: Buy
Price Target: $70 → $74
Current: $4.07
Upside: +1,718.18%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $86.00
Upside: +22.09%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $31.70
Upside: +161.83%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $227.17
Upside: +14.45%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $81.10
Upside: -